These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 22935463

  • 21. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
    Li X, Lv R, He Q, Li H, Du X, Lin W, Li Q, He X, Wang S, Chen J.
    J Nephrol; 2008; 21(4):584-91. PubMed ID: 18651550
    [Abstract] [Full Text] [Related]

  • 22. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
    Li X, Ren H, Zhang Q, Zhang W, Wu X, Xu Y, Shen P, Chen N.
    Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
    [Abstract] [Full Text] [Related]

  • 23. Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression.
    Chan TM, Li FK, Hao WK, Chan KW, Lui SL, Tang S, Lai KN.
    Lupus; 1999 Apr; 8(7):545-51. PubMed ID: 10483033
    [Abstract] [Full Text] [Related]

  • 24. Long-term effects of tacrolimus for maintenance therapy of lupus nephritis: a 5-year retrospective study at a single center.
    Karasawa K, Uchida K, Kodama M, Moriyama T, Nitta K.
    Rheumatol Int; 2018 Dec; 38(12):2271-2277. PubMed ID: 30203113
    [Abstract] [Full Text] [Related]

  • 25. Clinical assessment of tacrolimus therapy in lupus nephritis: one-year follow-up study in a single center.
    Asamiya Y, Uchida K, Otsubo S, Takei T, Nitta K.
    Nephron Clin Pract; 2009 Dec; 113(4):c330-6. PubMed ID: 19729969
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of tacrolimus for induction therapy in patients with active lupus nephritis.
    Takahashi S, Hiromura K, Sakurai N, Matsumoto T, Ikeuchi H, Maeshima A, Kaneko Y, Kuroiwa T, Nojima Y.
    Mod Rheumatol; 2011 Jun; 21(3):282-9. PubMed ID: 21188448
    [Abstract] [Full Text] [Related]

  • 27. Long-term data on tacrolimus treatment in lupus nephritis.
    Yap DY, Ma MK, Mok MM, Kwan LP, Chan GC, Chan TM.
    Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of tacrolimus versus mycophenolate mofetil as induction treatment and low-dose tacrolimus as treatment for lupus nephritis: a meta-analysis.
    Lee YH, Song GG.
    Z Rheumatol; 2023 Nov; 82(9):754-762. PubMed ID: 36607421
    [Abstract] [Full Text] [Related]

  • 29. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [Abstract] [Full Text] [Related]

  • 30. High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide.
    Benenson E, Fries JW, Heilig B, Pollok M, Rubbert A.
    Clin Rheumatol; 2005 Jun; 24(3):251-7. PubMed ID: 15940558
    [Abstract] [Full Text] [Related]

  • 31. Renal outcome in patients with lupus nephritis using a steroid-free regimen of monthly intravenous cyclophosphamide: a prospective observational study.
    Fischer-Betz R, Chehab G, Sander O, Vordenbäumen S, Voiculescu A, Brinks R, Schneider M.
    J Rheumatol; 2012 Nov; 39(11):2111-7. PubMed ID: 22984276
    [Abstract] [Full Text] [Related]

  • 32. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 33. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study.
    Mehra S, Usdadiya JB, Jain VK, Misra DP, Negi VS.
    Rheumatol Int; 2018 Apr; 38(4):557-568. PubMed ID: 29450636
    [Abstract] [Full Text] [Related]

  • 34. Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial.
    Zhang M, Qi C, Zha Y, Chen J, Luo P, Wang L, Sun Z, Wan J, Xing C, Wang S, Jiang G, Sun M, Chen Q, Chen J, Li D, Guan T, Ni Z.
    Clin Rheumatol; 2019 Mar; 38(3):859-867. PubMed ID: 30426311
    [Abstract] [Full Text] [Related]

  • 35. Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis.
    Lee T, Oh KH, Joo KW, Kim YS, Ahn C, Han JS, Kim S, Chin HJ.
    Lupus; 2010 Jul; 19(8):974-80. PubMed ID: 20581020
    [Abstract] [Full Text] [Related]

  • 36. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G, Raffiotta F, Trezzi B, Giglio E, Mezzina N, Del Papa N, Meroni P, Messa P, Sinico AR.
    Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
    [Abstract] [Full Text] [Related]

  • 37. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Baldovino S, Menegatti E, La Grotta R, Modena V.
    Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
    [Abstract] [Full Text] [Related]

  • 38. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study.
    Tanaka H, Oki E, Tsugawa K, Nonaka K, Suzuki K, Ito E.
    Lupus; 2007 Dec; 16(11):896-900. PubMed ID: 17971363
    [Abstract] [Full Text] [Related]

  • 39. Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome.
    Yap DY, Yu X, Chen XM, Lu F, Chen N, Li XW, Tang CS, Chan TM.
    Nephrology (Carlton); 2012 May; 17(4):352-7. PubMed ID: 22295934
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials.
    Lee YH, Lee HS, Choi SJ, Dai Ji J, Song GG.
    Lupus; 2011 May; 20(6):636-40. PubMed ID: 21382917
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.